Wellington Management Group’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-723,118
| Closed | -$52.2M | – | 1987 |
|
|
2025
Q4 | $52.2M | Sell |
723,118
-9,342,069
| -93% | -$603M | 0.01% | 726 |
|
|
2025
Q3 | $439M | Buy |
10,065,187
+815,497
| +9% | +$33M | 0.08% | 225 |
|
|
2025
Q2 | $263M | Sell |
9,249,690
-434,866
| -4% | -$13M | 0.05% | 301 |
|
|
2025
Q1 | $286M | Buy |
9,684,556
+1,578,459
| +19% | +$49.2M | 0.06% | 267 |
|
|
2024
Q4 | $236M | Buy |
8,106,097
+1,075,148
| +15% | +$44.9M | 0.04% | 333 |
|
|
2024
Q3 | $323M | Buy |
7,030,949
+3,228,923
| +85% | +$140M | 0.06% | 285 |
|
|
2024
Q2 | $155M | Buy |
3,802,026
+2,573,028
| +209% | +$73.8M | 0.03% | 440 |
|
|
2024
Q1 | $31.4M | Buy |
1,228,998
+937,780
| +322% | +$14.7M | 0.01% | 838 |
|
|
2023
Q4 | $2.64M | Buy |
291,218
+43,147
| +17% | +$288K | ﹤0.01% | 1436 |
|
|
2023
Q3 | $1.58M | Buy |
248,071
+12,835
| +5% | +$111K | ﹤0.01% | 1518 |
|
|
2023
Q2 | $2.61M | Buy |
235,236
+91,366
| +64% | +$1.15M | ﹤0.01% | 1430 |
|
|
2023
Q1 | $2.21M | Buy |
143,870
+5,461
| +4% | +$120K | ﹤0.01% | 1491 |
|
|
2022
Q4 | $3.07M | Sell |
138,409
-59,884
| -30% | -$893K | ﹤0.01% | 1394 |
|
|
2022
Q3 | $3.24M | Sell |
198,293
-869,930
| -81% | -$16.6M | ﹤0.01% | 1400 |
|
|
2022
Q2 | $15.5M | Sell |
1,068,223
-67,521
| -6% | -$1M | ﹤0.01% | 1011 |
|
|
2022
Q1 | $21M | Buy |
1,135,744
+112,024
| +11% | +$1.9M | ﹤0.01% | 1003 |
|
|
2021
Q4 | $24.3M | Buy |
1,023,720
+414,457
| +68% | +$9.9M | ﹤0.01% | 1029 |
|
|
2021
Q3 | $15M | Buy |
609,263
+141,807
| +30% | +$3.08M | ﹤0.01% | 1157 |
|
|
2021
Q2 | $11.6M | Buy |
467,456
+151,445
| +48% | +$3.52M | ﹤0.01% | 1228 |
|
|
2021
Q1 | $6.89M | Sell |
316,011
-225,404
| -42% | -$5.52M | ﹤0.01% | 1348 |
|
|
2020
Q4 | $13.8M | Sell |
541,415
-206,692
| -28% | -$6.03M | ﹤0.01% | 1104 |
|
|
2020
Q3 | $21.1M | Sell |
748,107
-126,981
| -15% | -$3.67M | ﹤0.01% | 944 |
|
|
2020
Q2 | $24.7M | Buy |
+875,088
| New | +$25.2M | 0.01% | 880 |
|
Other funds holding RNAM
Wellington Management Group's RNAM Position: Q1 2026 in Review
Wellington Management Group sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 723,118 shares — an estimated $52.2M sold.
Wellington Management Group first reported a position in RNAM in Q2 2020 and held it in 23 quarters. The position peaked at $439M in Q3 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- Wellington Management Group reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- Wellington Management Group sold 723,118 Avidity Biosciences shares in Q1 2026, an estimated $52.2M.
- Wellington Management Group first reported a position in Avidity Biosciences in Q2 2020 and held it in 23 quarters.
- Wellington Management Group's Avidity Biosciences position peaked at $439M in Q3 2025.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.